Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hackl

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Hemorheology and Microcirculation|June 10, 2017
Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignanciesN Platz Batista da Silva, L P Beyer, M C Hottenrott, et al.
Medical Oncology (Northwood, London, England)|November 4, 2017
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trialI Walter, U Schulz, M Vogelhuber, et al.
ESMO Open|April 23, 2022
Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancerG Filippini Velázquez, S Schiele, M Gerken, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Hemorheology and Microcirculation|June 10, 2017
Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignanciesN Platz Batista da Silva, L P Beyer, M C Hottenrott, et al.
Medical Oncology (Northwood, London, England)|November 4, 2017
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trialI Walter, U Schulz, M Vogelhuber, et al.
ESMO Open|April 23, 2022
Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancerG Filippini Velázquez, S Schiele, M Gerken, et al.
Pageof 2